Privacy Policy

Intendis respects the privacy of visitors to Intendis Web sites. The following statement generally describes the types of information collected at Intendis sites and the uses made of it.

Personally Identifiable Information

Intendis collects personally identifiable information such as name, address, telephone number, e-mail address, or other information only when it is voluntarily submitted to us on this site. Intendis uses or discloses personally identified information only with the visitor's consent or other legal, privacy, or terms and conditions authorization. The intended uses of the information are provided at the site where the information is collected. We may use the information to improve the content of our Web site. We will not sell or rent personally identifiable information to any third party for that party's marketing purposes.

Non-Personally Identifiable Information

Intendis also collects aggregate or non-personally identifiable information in aggregate form to track data such as the total number of visits to our Web sites, the number of visitors to each page of our Web sites, and the domain names of our visitors' Internet service providers. We use this information, which remains in aggregate form, to understand how our visitors use our Web sites so that we may make them better. We may also share this information with our partners or other outside companies. NO PERSONALLY IDENTIFIABLE INFORMATION IS DISCLOSED IN THIS PROCESS.

Voluntary Disclosures

Any communications or material that you transmit to, or post on, the site by electronic mail or otherwise, including any data, questions, comments, suggestions, or the like, is, and will be treated as, non-confidential and non-proprietary information, and Intendis shall have no obligation of any kind with respect to such information except as otherwise stated in this privacy statement.

Links to Other Web Sites

Intendis Web sites provide links to other Web sites as a service to our viewers. These Web sites we believe provide helpful information. However, Intendis does not endorse and is not responsible for the content of third-party sites. Nor does Intendis have any control over the information you may choose to provide these sites. The privacy policy described here does not apply to those sites.

Children

Intendis does not request, nor specifically collect, information from children. Any information that is collected passively is handled as non-personally identifiable information.

Changes

Any changes to this privacy policy will be communicated promptly on this page.



INDICATION & USAGE


Desonate Gel is indicated for the treatment of mild to moderate atopic dermatitis in patients 3 months of age and older.

IMPORTANT SAFETY INFORMATION


As with other corticosteroids, therapy should be discontinued when control is achieved. Unless directed by a physician, the treated skin area should not be bandaged so as to be occlusive. Systemic absorption of topical corticosteroids, including Desonate Gel, has produced HPA axis suppression, for which pediatric patients are more susceptible.

In clinical trials, the most frequent adverse events included headache (2%), application site burning (1%), rash (1%), and application site pruritus (<1%). The safety of Desonate Gel has not been established beyond 4 weeks of use.

Desonate Gel is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Desonate Gel is for topical use only. Desonate Gel is not for ophthalmic, oral, or intravaginal use.

Desonate Gel is not indicated for the treatment of diaper dermatitis.

Please see full prescribing information for Desonate.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.FDA.gov/medwatch or call 1-888-INFO-FDA.

Intendis reserves the right to terminate or modify this Instant Savings program at its sole discretion and without notice. Desonate® is a registered trademark of Intendis, Inc.